Oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by developing and commercializing safer and more effective therapeutics

Sectors
Healthcare
Life Sciences
First Invested
2010
Early
Company Status
IPO/Acquired
NASDAQ: TSRO
Acquired by GlaxoSmithKline
Associated Team
Paul Walker